Literature DB >> 8423359

Determining confidence limits for drug potency in immunoassay.

W G Alvord1, J L Rossio.   

Abstract

Nonlinear models have frequently been used to characterize dose-response data obtained from biological assays. The effect of a bioactive agent is observed and the model allows prediction of the dose required to obtain the observed effect (the 'inverse prediction'). The precision of this estimate is important in potency determination. Here, a general method is presented for calculating the inverse confidence intervals for estimates of dose potencies obtained from nonlinear models often used to describe these tests. The approach is demonstrated with application of data sets to the negative exponential and four-parameter logistic regression models. Necessary theory is presented and followed by detailed discussion in which estimation strategies are explained and intermediate quantities calculated.

Mesh:

Year:  1993        PMID: 8423359     DOI: 10.1016/0022-1759(93)90082-i

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method.

Authors:  Shengyu Fu; Qi Zhao
Journal:  Antibodies (Basel)       Date:  2022-08-16

2.  Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.

Authors:  Bih-Rong Wei; Shelley B Hoover; Mark M Ross; Weidong Zhou; Francesco Meani; Jennifer B Edwards; Elizabeth I Spehalski; John I Risinger; W Gregory Alvord; Octavio A Quiñones; Claudio Belluco; Luca Martella; Elio Campagnutta; Antonella Ravaggi; Ren-Ming Dai; Paul K Goldsmith; Kevin D Woolard; Sergio Pecorelli; Lance A Liotta; Emanuel F Petricoin; R Mark Simpson
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.